Genpact Ltd CFO Michael Weiner Steps Down; Transitional Exit Through Mar 31, 2027

What Happened
Genpact Ltd announced that Michael Weiner stepped down as Chief Financial Officer effective September 8, 2026 and will remain employed in a transitional capacity through March 31, 2027 (the “Separation Date”). The company and Mr. Weiner executed a Separation Agreement dated September 15, 2026 that outlines severance, cash payments, and treatment of outstanding equity awards.

Key Details

• Severance and cash: $683,500 (equal to 12 months of base salary) to be paid in equal installments over the 12 months after the Separation Date; $45,327 lump sum to cover 18 months of continued health coverage; $168,534 lump sum representing prorated target bonus for calendar 2027.
• Equity and options: Certain unvested restricted share units will accelerate vesting as of the Separation Date; certain performance share awards and RSUs will vest as if Mr. Weiner had remained employed for 12 months after the Separation Date (performance award payout based on achievement levels). Previously vested options remain exercisable for six months after the Separation Date (or until option expiration).
• Conditions: Payments and benefits are conditioned on Mr. Weiner signing a general release (and re-executing a release at the Separation Date) and complying with one-year post-Separation covenants (non-compete, non-solicit), confidentiality, and non-disparagement obligations.

Why It Matters
This 8-K reports a change in senior finance leadership—material information for investors tracking corporate governance and management continuity. The Separation Agreement defines the one-time cash and equity-related amounts the company may incur and how Mr. Weiner’s outstanding awards will be treated, which can affect dilution and near-term compensation expense. The transitional period through March 31, 2027 provides for an orderly handover, while post-Separation covenants limit competitive and solicitation activity by Mr. Weiner.